Hyacorp Body Contouring MLF1 (1x10 ml)

Alcohol consumption should be avoided for 24 hours before and 48 hours after the procedure. As a vasodilator, alcohol can significantly exacerbate post-filler swelling and increase the risk of hematomas, particularly when larger volumes of product are administered.

Injectable treatments are not recommended during the lactation period. It is advised to postpone elective body contouring until breastfeeding has concluded to ensure the highest safety for both mother and infant.

The formulation contains 20 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 2 mg/ml of non-cross-linked HA, provided in a 10 ml syringe for comprehensive body volumization.

The dosage is highly individualized depending on the treatment area. For hand rejuvenation, a standard dose is often 2.5 ml to 5 ml per side. For calf augmentation or correction of deformities, the dosage can range from 10 ml to 30 ml per session. Practitioners should follow strict protocols for deep subcutaneous or supraperiostal administration to avoid superficial filler lumps.

Common side effects include localized swelling, redness, and purple bruising at the injection site. Hardness or sensitivity in the treated area may persist for up to two weeks. To manage post-procedure inflammation, patients should follow a specific aftercare protocol, which includes avoiding strenuous exercise for 7 days.

Hyacorp MLF1 works by supplementing the intercellular matrix with a biphasic HA gel that resists mechanical displacement. The large particle size ensures a high lifting capacity and prevents product migration, which is critical in mobile areas like the calves. Unlike facial skin boosters, this product focuses on long-term structural volume rather than just epidermal hydration.

This treatment is strictly contraindicated for pregnant women. There is no clinical safety data regarding the use of large-volume HA body fillers during fetal development. We maintain high safety standards and recommend waiting until after childbirth and the cessation of breastfeeding.